Investment giant Pimco took to Twitter on Friday to outline its forecast that inflation throughout Europe as well as new bouts of quantitative easing could lead to trouble.
"Quantitative easing by the European Central Bank appears increasingly ineffective," the company said in a linked-to report, noting that the ECB's balance sheet has increased by more than two trillion euros, or about $2.3 billion, since November 2014. Meanwhile, price levels in the currency block have been climbing.
Pimco sees the central bank's effort to buy debt securities from the open market as fruitless, especially as higher prices frustratethe ECB's plans to add liquidity to the market though bouts of quantitative easing.
"Nonetheless, we expect the ECB will continue its heavy lifting and eventually even pursue an extension of the QE program that will approach de facto if not de jure monetization of fiscal deficits," Pimco said. "We see eurozone inflation remaining somewhat below 2% over the secular horizon of five years."
Meanwhile, Goldman Sachs (GS) also tweeted a video on small-business success, highlighting the advice of Michael Bloomberg, Warren Buffett and Jack Dorsey.
"There's no substitute for hard work," Bloomberg said in the video,"People say luck, yes, but the harder the work the luckier you get."
Martin Shkreli -- the former CEO of MSMB Capital Management who was arrested last December on fraud charges over allegations he used funds from Retrophin, the pharmaceutical company he founded in 2011, to pay off investments in his MSMB Capital fund -- also tweeted on Friday, offering his thoughts on the valuation of Horizon Pharma (HZNP) stock. Shares of the specialty drugmaker closed at $17.88 in Friday trading.